Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
Related Posts
China’s first-quarter GDP tops estimates at 5.4% as growth momentum continues amid tariff worries
Several investment banks have moved to slash China’s growth forecasts this year, with most doubting Beijing can achieve the official target of “around 5%” this year.
Judge blocks Trump administration mass layoffs at many U.S. agencies
The Trump administration has already asked the Supreme Court to block an earlier version of the order on efforts to reorganize the federal bureaucracy.
Stocks making the biggest moves premarket: Delta Air Lines, WK Kellogg, PTC, AMD and more
These are some of the stocks posting the largest moves in premarket trading Thursday.